dipyridamole has been researched along with Diaphragmatic Hernia in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Congenital diaphragmatic hernia (CDH) remains a frustrating cause of respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN)." | 1.30 | Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. ( Farnoux, C; Hartman, JF; Mercier, JC; Saizou, C; Thébaud, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GRIEP, AH | 1 |
| Kinsella, JP | 1 |
| Torielli, F | 1 |
| Ziegler, JW | 1 |
| Ivy, DD | 1 |
| Abman, SH | 1 |
| Thébaud, B | 2 |
| Saizou, C | 1 |
| Farnoux, C | 1 |
| Hartman, JF | 1 |
| Mercier, JC | 2 |
| de Lagausie, P | 1 |
| Forgues, D | 1 |
| Aigrain, Y | 1 |
| Dinh-Xuan, AT | 1 |
| Buysse, C | 1 |
| Fonteyne, C | 1 |
| Dessy, H | 1 |
| De Laet, MH | 1 |
| Biarent, D | 1 |
5 other studies available for dipyridamole and Diaphragmatic Hernia
| Article | Year |
|---|---|
NOCTURNAL ANGINA PECTORIS.
Topics: Angina Pectoris; Coronary Disease; Dipyridamole; Duodenal Obstruction; Heart Failure; Heart Valve Di | 1964 |
Dipyridamole augmentation of response to nitric oxide.
Topics: Dipyridamole; Drug Synergism; Hernia, Diaphragmatic; Humans; Infant, Newborn; Nitric Oxide; Persiste | 1995 |
Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia.
Topics: Administration, Inhalation; Dipyridamole; Fatal Outcome; Hernia, Diaphragmatic; Hernias, Diaphragmat | 1999 |
ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Cyclic GMP; Dipyridamole; Disease Models, Animal; E | 2000 |
The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia.
Topics: Dipyridamole; Extracorporeal Membrane Oxygenation; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Co | 2001 |